Rutgers The State University of New Jersey technology UAdaptors that silences gene expression via completely different mechanism current techniques. ROUND Amy Cowperthwait RN MSN ACNSBC and Bucha University of Delaware team nurses engineers at the is revolutionizing training healthcare workers starting with techniques for emergency airway management by developing new mannequin simulation tools. Temple University A potential drug therapy for Amyotrophic Lateral Sclerosis ALS Lou Gehrig disease popularly known [...]

Levison Ph. Temple University Portable Spinner of Aqueous Soy Solutions for Wound Healing Applications Patricia McLaughlin . Lehigh University Ultrahigh Speed Ophthalmic Optical Coherence Tomography OCT Archive Rounds Treena Arinzeh . S [...]

Rutgers University Magnesium zinc oxide based thin film transistor biosensor MZObioTFT for biochemical diagnostics with high sensitivity and selectivity Yanming Wang Ph. The outcome to date Ten licensed technologies including eight startup companies formed that have potential positively disrupt healthcare landscape. S [...]

New Jersey Institute of Technology is reducing recovery time and cost associated with bone grafting procedures. Drexel of Medicine Preclinical optimization KA and novel therapeutics for Scleroderma Alessandro Fatatis . Rutgers The State University of New Jersey therapeutic compound for pancreatic cancer one most difficult to treat. ROUND Benjamin Blass Ph [...]

MPH Children s Hospital of Philadelphia Actualizing the promise Digital Health Revolution through cloudbased evaluation platform Joseph . ELIGIBILITY CRITERIA Affiliation with QED partner institution Support from home Technology Transfer Office Life sciences focused idea strong desire and willingness to learn receive guidance industry experts each annual cycle proposals are solicited via RFP calling for submission brief White Paper applications. The QED Program is administered through Technology Transfer Office each partner research organization listed below [...]

RDS by Check In RESULTS. lengthf new wpc Inst hed ge b context TP var ipd ipt secall true false sj evt nd function args QueryID fbpkgiid SERP. D Ph. Temple University A New Cyclin Dependent Kinase Inhibitor Selective for CDK and Peter Lelkes Ph [...]

Samuel Gunderson Ph. The QED program provides an ideal funding opportunity that will support next stage of our research advancing compound leads into potential drug candidates. Each research institution retains ownership of all intellectual property. BUSINESS ADVISORS The Science Center community of industry professionals and serial entrepreneurs serve as QED [...]

Penn State College of Medicine Development Subarachnoid to Sagittal Sinus CSF Drainage System Charles Roth Ph. Market Exposure participants present their Proofof Concept Plans to Selection Team pharma executives and investors. display block return if function yle [...]

Your taxdeductible gift helps us move ideas forward. Thomas Jefferson University Invivo Studies of SirT Activator for Androgen Independent Prostate Cancer Eric Wickstrom B. Children s Hospital of Philadelphia novel treatment for people infected with hepatitis virus using microRNA technology that interferes the ability to express its own genes. They work with investigators and Technology Transfer Offices evaluate goto market strategy prepare funding plan for each [...]

University of Delaware potential drug therapy for prostate cancer developed from novel class compounds. Temple University Development of Amphiphilic Antibiofilm Antibacterial Agents Chao Zhou . Below is a sampling of our Business Advisors [...]

End u. We re seeking technologies that have clear product potential life science and healthcare markets. Nov [...]

ROUND Benjamin Blass Ph. The Australianbased global biotechnology leader will leverage our expertise and promising research being developed at institutions across Greater Philadelphia to build its pipeline broaden collaborative networks United States [...]